Preferential increase in high-molecular weight adiponectin after niacin

Area of Science:

• Endocrinology and Metabolism
• Pharmacology
• Biochemistry

Background:

• Niacin treatment has been shown to increase adiponectin levels in patients with metabolic syndrome.
• Adiponectin exists in different molecular weight forms, with high-molecular weight (HMW) adiponectin considered the most biologically active.
• Metabolic syndrome is associated with insulin resistance and cardiovascular risk.

Purpose of the Study:

• To investigate if niacin equally increases all three adiponectin fractions (low, medium, and high molecular weight).
• To determine if the increase in HMW adiponectin can prevent the decline in insulin sensitivity observed with niacin treatment.
• To explore the relationship between baseline BMI, insulin sensitivity, and HMW adiponectin response to niacin.

Main Methods:

• Analysis of sera from a randomized, double-blind, placebo-controlled study involving 20 men with metabolic syndrome.
• Participants received 1500 mg of niacin daily for 6 weeks.
• Measurement of adiponectin fractions and assessment of insulin sensitivity using HOMA-IR.

Main Results:

• Niacin significantly increased HMW adiponectin by 88% (p<0.05), while low- and medium-molecular weight fractions increased by 35% and 33%, respectively.
• The increase in HMW adiponectin was more pronounced in patients with lower BMI and better baseline insulin sensitivity.
• Despite the significant increase in HMW adiponectin, niacin treatment led to a deterioration of insulin sensitivity (HOMA-IR).

Conclusions:

• High-molecular weight adiponectin is the primary fraction elevated by niacin treatment in metabolic syndrome patients.
• The observed improvement in HMW adiponectin levels does not mitigate the negative impact of niacin on insulin sensitivity.
• Niacin-induced insulin resistance occurs independently of the magnitude of HMW adiponectin increase.